Gesundheit Österreich was commissioned by the Global AMR R&D Hub to conduct a study to inform national policy makers about options in addressing novel antibiotic and diagnostic pricing,…
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
Novel policy options for reimbursement, pricing and procurement of AMR health technologies
Measures to address medicines shortages in 24 countries
Experts of the Pharmacoeconomics Department conducted a survey in 24 countries on measures that governments implemented to address medicines shortages. Common policies include a notification…
Online Summer School Pharmaceutical Pricing and Reimbursement Policies 2021
5-9 July 2021 The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies is pleased to announce the first Online Summer School on Pharmaceutical Pricing and Reimbursement…